Objective-To develop and validate a hierarchical decision tree model, combining neurobehavioral and physical measures, for identification of children affected by prenatal alcohol exposure even when facial dysmorphology is not present.
Study design-Data were collected as part of a multisite study across the United States. The model was developed after evaluating over 1000 neurobehavioral and dysmorphology variables collected from 434 children (8-16y) with prenatal alcohol exposure, with and without fetal alcohol syndrome (FAS), and non-exposed controls, with and without other clinically-relevant behavioral or cognitive concerns. The model was subsequently validated in an independent sample of 454 children in two age ranges (5-7y or 10-16y). In all analyses, the discriminatory ability of each model step was tested with logistic regression. Classification accuracies and positive and negative predictive values were calculated. Results-The model consisted of variables from 4 measures (2 parent questionnaires, an IQ score, and a physical examination). Overall accuracy rates for both the development and validation samples met or exceeded our goal of 80% overall accuracy.
Conclusions-The decision tree model distinguished children affected by prenatal alcohol exposure from non-exposed controls, including those with other behavioral concerns or conditions. Improving identification of this population will streamline access to clinical services, including multidisciplinary evaluation and treatment.
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Fetal Alcohol Spectrum Disorders (FASD); Fetal Alcohol Syndrome (FAS); Clinical Identification; Prenatal Alcohol Exposure; Screening Tool Fetal alcohol spectrum disorders (FASD) are characterized by a range of physical and neurobehavioral changes caused by prenatal alcohol exposure [1, 2] and occur in as many as 4.8% of school-age children [3] . Although fetal alcohol syndrome (FAS) is readily identifiable by trained clinicians [4] , the majority of children affected by prenatal alcohol exposure present with significant neurobehavioral impairments without sufficient dysmorphology to merit the diagnosis of FAS. This heterogeneity of physical presentation coupled with an overlap in clinical presentation with other neurodevelopmental disorders, such as attention-deficit/hyperactivity disorder (ADHD), results in under-identification, misdiagnosis, and misunderstanding of the etiology of difficulties faced by children with FASD [5, 2] . Failure to identify alcohol-affected children can adversely affect prognosis and access to tailored services [6] . However, although efforts to identify affected individuals have been moderately successful [7] [8] [9] [10] , they have not translated easily to clinical settings, perhaps due to the difficulty in differentiating alcohol-affected children from those with similar behavioral concerns without prenatal alcohol exposure and the extensive neuropsychological testing required.
Thus, there is a need for an efficient but specific primary screening tool for use by pediatricians to identify children with neurobehavioral impairments that may be due to prenatal alcohol exposure. Positive screens would compel referral for additional medical or developmental evaluations or to an FASD clinic for full evaluation. We aimed to develop and validate a clinically relevant, feasible, and accurate (>80%) [11] decision tree model that could differentiate children affected by prenatal alcohol exposure from non-exposed children with and without other clinically relevant behavioral or cognitive concerns or conditions.
Methods
Data were collected as part of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), a multisite, multimethod study of FASD. Data for model development and model validation samples were collected in the second (CIFASD II; 2007-2012) and third (CIFASD III, ongoing) phases of the study, respectively. Both phases included standardized neuropsychological assessment and dysmorphology evaluations [12] . Many of the same measures were included in both phases, although different assessments of general cognitive ability were used (CIFASD II: Wechsler Intelligence Scale for Children-Fourth Edition [WISC-IV] [13] ; CIFASD III: Differential Ability Scales-Second Edition [DAS-II] [14] ). Both phases included a heterogeneous comparison group (Non-AE group) comprising non-exposed (<1 drink/week, never >2 drinks/occasion) typically-developing children and non-exposed children with clinical conditions or concerns (approximately 30-50% of comparison subjects). The most common concerns in the comparison group were related to ADHD, other internalizing and externalizing problems, low IQ, and learning disorders, which are relatively representative of the populations of an outpatient pediatric psychology or psychiatry clinic.
Prenatal alcohol exposure histories were obtained through retrospective maternal report or social service, legal, or medical records. Subjects were included in the alcohol-exposed (AE) group if a history of heavy prenatal alcohol exposure (>13 drinks/week or >4 drinks/ occasion during pregnancy) was known or when such exposure was suspected in a child with an FAS diagnosis. In many cases, accurate exposure history was unattainable; children were included in the AE group if mothers were known to be "alcoholic" or alcohol abusing during pregnancy. All subjects were evaluated using a standardized dysmorphology examination conducted by a member of the CIFASD Dysmorphology Core [4, 12] . Informed consent and assent were obtained from caregivers and subjects prior to testing. Financial incentive for participation and written feedback was provided after evaluation. The Institutional Review Boards at San Diego State University and other CIFASD sites approved this study. Demographic information is presented in Table I .
Model Development Sample
Data from 434 subjects aged 8-16 years (Mean [M]=12.3) were used in the development of the decision tree model. Thirty-nine (26.7%) subjects in the AE group met criteria for FAS [4, 12] . One hundred forty-seven (51.0%) subjects in the Non-AE group had clinically concerning behaviors or conditions, including 93 (32.3%) subjects who met criteria for ADHD based on the Computerized Diagnostic Interview Schedule for Children-Fourth Edition (C-DISC-4.0) [15] [16] [17] .
Model Validation Sample
Data from 454 subjects aged either 5-7 years (Child; M=6.6, n=165) or 10-16 years (Adolescent; M=13.4, n=289) were used for model validation. 7 (12.7%) subjects in the (30.0%) children and 38 (19.9%) adolescents who met criteria for ADHD based on the C-DISC-4.0.
Decision Tree Development
Over 1000 composite and subtest scores from measures assessing verbal and nonverbal memory, executive functioning, verbal comprehension, perceptual reasoning, working memory, processing speed, psychopathology, adaptive behavior, and dysmorphology were considered for inclusion in the model. For continuous variables (i.e., neuropsychological measures), cut-off scores based on normed clinical levels of impairment were sequentially refined into binary scores that maximized each measure's ability to differentiate between AE and Non-AE groups. Categorical variables (i.e., dysmorphology measures) were retained as binary values indicating presence or absence of a feature. Additionally, composite variables that included multiple subscales from a single measure were created (e.g., combining the binary indicators from multiple indexes in the WISC-IV into one variable). These variables were retained as binary values indicating whether criteria was met on a specific number of included subscales, with cutoffs determined through logistic regression.
Between-subject analyses of variance (ANOVAs) were conducted to obtain the effect size (partial η 2 ) corresponding to the group differences (AE vs. Non-AE) for each variable. Variables with partial η 2 <.1 were eliminated, resulting in 40 retained variables for further consideration. These variables were added sequentially to the decision tree, beginning with the largest effect sizes. Variables' discriminatory abilities were retested through logistic regression to obtain odds ratio values (OR) and significance levels (p-values) for each binary indicator at its position within the tree [18] . Variables were added to paths within the decision tree model until sample size prohibited further discrimination (<10 subjects in a single group) or no variables were found that could significantly differentiate between AE and Non-AE subjects. Once we established the initial version of the tree, we tested substitutions of other variables that discriminated between AE and Non-AE groups with a medium to large effect size. Over 150 different orders and combinations of variables were examined to produce the most efficient and parsimonious tree while maximizing overall accuracy rates (correctly identified subjects/total subjects). Cut-off scores, odds ratios, and other statistical results, as well as a list of the measures and number of variables per measure that were considered for inclusion in the decision tree, are included in Tables II-V (Tables  III-V ; available at www.jpeds.com).
Subject group membership (AE or Non-AE) was determined upon enrollment into the CIFASD project based on knowledge of exposure history. Comparison of actual group membership with proposed group membership enabled calculation of overall accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the final decision tree model. For all statistical tests, an alpha level of p<.05 indicated significance and p-values between .05 and.08 indicated marginal significance. Two routes through the decision tree were tested: (1) a child who presents to a pediatrician with suspicion of prenatal alcohol exposure or with concerning physical or behavioral features (Pediatrician route); and (2) a child who presents to a psychologist with concerns about neurobehavioral impairment (Psychologist route) and is subsequently referred to the pediatrician based on results from psychopathology and IQ tests. The proposed decision tree is presented in the Figure. 
Results
Demographic data were analyzed by chi-square or ANOVA. In the development sample (CIFASD II), the AE and Non-AE groups differed on ethnicity (p=.01), race (p=.02), site (p=.01), full scale IQ (FSIQ; p<.001), and rate of ADHD diagnosis (p<.001), but not on sex, handedness, or age (p>.11). In the validation sample (CIFASD III), the AE and Non-AE groups in the Child sample differed on general conceptual ability (GCA; p<001) and rate of ADHD diagnosis (p<001), but not on sex, ethnicity, race, handedness, age, or site (p>.08). In the Adolescent sample, the AE and Non-AE groups differed on age (p=01), GCA (p<.001), and rate of ADHD diagnosis (p<001), but not on sex, ethnicity, race, handedness, or site (p>. 26).
Accuracy Rate Analyses
Overall accuracy rates across model development and validation samples were 79.5%-84.7% (Table VI) . Z-test analyses were conducted to examine whether the proportion of children correctly identified by the decision tree in each sample was significantly higher than chance (50% based on the inclusion of two groups). In the model development sample, overall classification accuracies using the Psychologist route (z=14.4, p<001, 95% CI [80.9, 87.9]) and Pediatrician route (z=12.5, p<.001, 95% CI [76.0, 83.8]) were higher than chance.
Logistic regression analyses revealed that the discriminatory ability of all measures was statistically significant across routes (p≤.02). In the model validation sample, overall classification accuracies using the Psychologist route (Child: z=8. 9 higher than chance in both age ranges. In both age ranges, logistic regression analyses revealed that the discriminatory ability of all individual measures in the tree was statistically significant (p≤.05), except for GCA (p≥.10).
Misclassified Subjects
Misclassified subjects were compared with correctly classified subjects in the development and validation samples to examine potential systematic sources of error. Age and FSIQ/GCA were tested using ANOVA. Sex, handedness, race, and ethnicity were tested using chi-square or Fisher exact test (when n in ≥1 cells <5). Compared with correctly identified AE subjects, misclassified AE subjects (i.e., exposed subjects misclassified as Non-AE) were younger, had a higher FSIQ/GCA score, a lower rate of ADHD diagnosis, and were less likely to be Hispanic. Compared with correctly identified Non-AE subjects, misclassified Non-AE subjects (i.e., Non-AE subjects misclassified as AE) were older, had a lower FSIQ/GCA score, a higher rate of ADHD diagnosis and left-handedness, and were less likely to be White.
Post-Hoc Analyses
To follow up our a priori analyses and to improve differential diagnosis ability, we examined the overall accuracy rates for various clinically-relevant scenarios, as follows: (1) limiting the non-exposed comparison group to include only subjects without known behavior/ cognitive problems (Psychologist route: 89.2%, Pediatrician route: 83.3%), (2) limiting the non-exposed comparison group to include only subjects with known behavior/cognitive problems (Psychologist route: 67.2%, Pediatrician route: 75.1%), (3) limiting the exposed group by excluding subjects with FAS (Psychologist route: 84.7%, Pediatrician route: 77.4%), (4) omitting dysmorphology measures from the model (Psychologist route: 80.2%, Pediatrician route: 79.0%), and (5) omitting neurobehavioral measures from the model (Pediatrician route: 68.6%).
To further ensure the robustness of our findings, we calculated accuracy rates for ten random samples of 100 children from the model development sample (10 AE, 90 Non-AE). Although the tree model considers each child individually and is not influenced by the number of affected children included, using this ratio of exposed to non-exposed subjects (10%) is closer to the rate of affected children in the general population than the ratio in the larger study (34%). Using this sample, application of the decision tree continued until sample sizes became too small for reliable comparison (n<5). The average overall accuracy rate from these 10 random samples was identical to the original analyses (M=84.6%).
Discussion
A diagnostic challenge arises in situations in which a clinician is asked to evaluate a child with neurodevelopmental problems who lacks physical features of FAS and has, at best, collateral reports of a history of prenatal alcohol exposure. The decision tree developed in this study differentiates children affected by prenatal alcohol exposure from non-exposed children using physical and neurobehavioral measures, even in the absence of a diagnosis of FAS. The model requires a limited number of measures that can be easily obtained as part of standard clinical practice.
Our model resulted in accuracy rates (79.5%-84.7%) similar to previous studies, which achieved up to 84.7% accuracy in differentiating children with FASD from non-exposed controls [7, 8] . However, there are several distinctions that support significant incremental validity and improved clinical utility of our model. Post-hoc analyses revealed high accuracy rates (85%) even after removing children with FAS, who are already reliably identified through dysmorphology exams. Exposed individuals without physical markers display cognitive and behavioral impairments similar to those found in FAS, thus accurate identification of these individuals could facilitate access to intervention and tailored treatment. Our post-hoc analyses also indicated that the combination of both neurobehavioral and dysmorphology measures resulted in the highest accuracy rates; reliance solely on dysmorphology measures resulted in reduced overall accuracy as many children affected by prenatal alcohol exposure present without dysmorphology. other clinical behavior conditions or concerns. Distinguishing children with alcohol exposure from the larger population of children with concerning behavior problems is more clinically relevant than the potentially easier comparison of differentiating alcohol-exposed children from typically developing children and represents a more traditional outpatient practice. Therefore, even though the inclusion of this diverse comparison group increased the difficulty of accurate diagnosis due to greater variance, it provided additional ecological validity to ensure that the model is well suited for differential diagnosis or screening within an outpatient clinic.
Our model utilized a hierarchical, rather than concurrent, application of a very small number of measures, promoting parsimony and clinical feasibility. By design, not all children require all measures, which reduces time requirements for both families and clinicians. Alcohol effects may be ruled out quickly by the psychologist if no parent-reported behavior problems exist and IQ is >92 (step 1 and 2 using Psychologist route). Additionally, the Psychologist route ensures economy of assessment, as children would only be referred to a pediatrician for clinical behavior problemsor IQ impairment based on assessment or record review. By design, children who are initially seen by the pediatrician (i.e., the Pediatrician route) do not require the same testing as those who begin with the psychologist, further ensuring efficiency of decision making. Moreover, clinical utility is enhanced through the use of cutoff scores, which provide easy application of the tree in clinical settings. Refinement of these cut-off scores may improve accuracy rates of the decision tree while still maintaining ease of use. Importantly, the decision points within the proposed tree resemble the algorithm for evaluation of FASD provided by American Academy of Pediatrics and Centers for Disease Control and Prevention (http://www.cdc.gov/ncbddd/fasd/curriculum/ fasdguide_web.pdf), although neurobehavioral impairments serve a larger role in our model, reflecting our multidisciplinary view of FASD. Moreover, the variables retained in the decision tree map on to the criteria for neurobehavioral disorder associated with prenatal alcohol exposure (ND-PAE) recently specified in the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) [17, 21] , providing validation for the criteria for ND-PAE and clinical relevance of our decision tree model.
In addition to overall accuracy rates, PPV and NPV percentages were significantly greater than chance, indicating increased likelihood that a child is actually alcohol-exposed when classified as such by the decision tree. However, the decision tree correctly identified subjects in the non-exposed group at a higher rate than the alcohol-exposed group across all comparisons. This suggests stronger specificity than sensitivity, reducing the risk of false positive identification, and promoting effective allocation of resources. Of note, our post-hoc analyses confirmed that differentiation of alcohol-affected children from non-exposed children with other clinical conditions or concerns is the most challenging. Although our accuracy rates were still significant and considerably higher than identification rates of children with FASD in a high risk population [5] , further refinement of the decision tree model may improve accuracy rates.
Although our sample is diverse in its racial and ethnic composition, accuracy was not tested in every possible combination of demographic factors, and clinical judgment should be used when interpreting these results and implementing the decision tree in clinical settings.
Another potential limitation is that the proportion of subjects with prenatal alcohol exposure in our sample likely does not reflect rates found in the population, given our targeted recruitment of this population. Although precise population estimates of alcohol consumption in pregnancy are not known, approximately one-third of our sample had histories of heavy prenatal alcohol exposure, which is likely higher than in the general population. As each child's classification is independent of other children, composition of the subject group should not affect accuracy rates. Further, our post hoc analyses with a more conservative proportion of exposed to non-exposed subjects yielded comparable results.
An additional limitation is the use of specific neurobehavioral tests in the decision tree. We used two different measures of general cognitive function with similar overall accuracy levels; however, other measures of behavior problems or adaptive function may lead to similar results. Although not tested in this study, it may be possible to use existing scores (e.g., IQ scores from school records) to complete the decision tree. Similar accuracy rates using measures that are widely available and require a shorter administration time would promote flexibility and efficiency of the tree in clinical settings.
Although overall accuracies were high, there was variation of accuracy rates at each stopping point in the tree due to small sample sizes. This supports the need for further research extending those nodes to potentially improve accuracy rates. Regardless, the order of measures in the final model produced the highest overall accuracy rates compared with over 150 other iterations tested in the current study, and was validated in two age ranges in the independent CIFASD III sample.
Finally, as part of model development, we assessed the differential ability of over 1000 variables separately, raising the possibility of potential increases in type one error. Even though the measures included in the tree had the highest differential ability and accuracy rates were retained in an independent validation sample, further refinement through replication studies using other independent samples would increase the robustness of the proposed model.
Pediatricians represent a critical contact point for families of children with known or suspected prenatal alcohol exposure and thus, in our model, are responsible for screening children for prenatal alcohol exposure, carrying out the physical examination, assessing adaptive behavior, and ultimately classifying a child as alcohol-exposed. This role is consistent with that proposed in the American Academy of Pediatrics FASD Toolkit (https:// www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/fetal-alcohol-spectrumdisorders-toolkit/Pages/default.aspx) as well as the screening for other diagnoses such as autism spectrum disorders (http://www.aafp.org/afp/2008/1201/p1301.html). Our model provides a means to determine which children with neurodevelopmental problems are likely to be affected by prenatal alcohol exposure and require clinical follow-up. When a child is identified as "Proposed AE" using this model, prenatal alcohol exposure should be considered as an etiological factor and additional evaluation through a multi-disciplinary team with expertise in FASD may be appropriate.
The ability to accurately distinguish individuals affected by prenatal alcohol exposure is of great clinical importance, given the high rates of missed diagnosis and misdiagnosis [5, 22] . Improving identification would also provide a basis for future research aimed at identifying developmental trajectories and refining intervention strategies. Currently there are very few studies in this area, as many children affected by prenatal alcohol exposure are not identified accurately. Thus, the information gained from the proposed model could inform new interventions specifically tailored toward the FASD population. Replication studies, including deployment in diverse clinical settings, will further enhance the clinical utility of this decision tree. Decision tree to identify youth as alcohol-exposed (AE) or non-exposed (Non-AE). Ovals, actors; diamonds, action steps; circles, each action step; and boxes, ending points in the decision tree. If a child presents directly to a pediatrician with a suspicion of prenatal alcohol exposure or concerning physical or behavioral findings, the pediatrician would work through the decision tree model by assessing for dysmorphology and adaptive behavior using the VABS. A child assessed by a psychologist would need to be referred to a pediatrician only if IQ was less than 92 or there were CBCL scores in the clinical range. 1 Table 1 Demographic Information for alcohol-exposed (AE) and non-exposed (Non-AE) groups in Child (5-7y) and Adolescent (10-16y) samples. Table 3 Logistic Regression Analyses for Psychologist/Pediatrician route in CIFASD II, CIFASD III Child (5-7y), and CIFASD III Adolescent (10-16y) samples. Table 4 Logistic Regression Analyses for Pediatrician route in CIFASD II, CIFASD III Child (5-7y), and CIFASD III Adolescent (10-16y) samples. Table 6 Accuracy percentages in the decision tree model for development (CIFASD II) and validation (CIFASD III) samples. 
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